Stock Market Reviews

Read and share opinions on CTSO (Cytosorbents Corporation) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...
  Nov 14, 2025
• CytoSorbents: Q3 Earnings Snapshot
  Nov 13, 2025
• CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update
  Nov 13, 2025
• CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London
  Nov 11, 2025
• CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights
  Oct 30, 2025
• In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer
  Oct 28, 2025
• CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen
  Sep 29, 2025
• CytoSorbents Provides DrugSorb-ATR Regulatory Update
  Sep 16, 2025
• CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day
  Sep 8, 2025
• CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference
  Sep 5, 2025
• CTSO: CytoSorbents Announces the De Novo denial on DrugSorb-ATR was upheld by the FDA. However, a Path to Approval Was Also Provided by the Agency.
  Aug 20, 2025
• CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR
  Aug 20, 2025
• CTSO: CytoSorbents High Margin Revenue Growth Supports Price Target of $4.00.
  Aug 13, 2025
• Cytosorbents Second Quarter 2025 Earnings: Beats Expectations
  Aug 10, 2025
• CytoSorbents: Q2 Earnings Snapshot
  Aug 7, 2025
• CytoSorbents Leads a New Era in Sepsis Treatment
  Jul 31, 2025
• CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights
  Jul 29, 2025
• Cytosorbents Corporation (NASDAQ:CTSO): Is Breakeven Near?
  Jul 2, 2025